TP53 and Li-Fraumeni syndrome: In humans, germline intronic alterations in TP53 have been reported in patients with the rare cancer predisposition syndrome, Li-Fraumeni Syndrome, which is associated with a significantly increased risk of sarcoma and breast cancer in particular [7].